These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4849197)

  • 1. [Modification of bone metastases of prostatic carcinoma using estrogens. Roentgenological follow-up study].
    Ludvik W; Riedl P; Zaunbauer W
    Z Urol Nephrol; 1974 Mar; 67(3):165-9. PubMed ID: 4849197
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognosis and treatment of prostatic carcinoma].
    Klug W
    Zentralbl Chir; 1968 Mar; 93(10):362-6. PubMed ID: 5674208
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trepanobiopsy of the iliac bone in the diagnosis of bone metastasis of prostate carcinoma and in control of the efficacy of estrogen therapy].
    Mazin VV; Komarova LI; Mazina NM
    Urol Nefrol (Mosk); 1977; (3):41-2. PubMed ID: 878087
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial of combined intermittent chemotherapy in prostatic cancers. Estrogen resistant metastases].
    Chauvin HF
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):397-8. PubMed ID: 4807868
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogen-resistant prostatic cancer with bone metastases: palliative chemotherapy with 5-fluorouracil and cyclophosphamide].
    Küss R; Khoury S; Richard F; Fourcade R; Frantz P; Capelle JP
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2478-9. PubMed ID: 80785
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radiodiagnosis of metastases from prostatic carcinoma].
    Jewdokimowa WM; Perelmann WM
    Radiol Diagn (Berl); 1967; 8(1):103-14. PubMed ID: 6078403
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoride therapy for pain in malignant bone disease.
    Scott WP
    Radiology; 1968 Mar; 90(3):588-90. PubMed ID: 4966742
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vascular accidents of estrogen therapy for prostatic cancer metastases].
    Jurascheck F
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):400-2. PubMed ID: 4804405
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endocrine-surgical treatment of skeletal metastases].
    Dagradi A; Petronio R
    Clin Ortop; 1972; 23(1):1-25. PubMed ID: 5084890
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostatic neoplasm with skeletal metastases. Exceptional survival and disappearance of the metastases after hormone therapy].
    Filippini U
    Minerva Urol; 1969; 21(6):232-4. PubMed ID: 5403841
    [No Abstract]   [Full Text] [Related]  

  • 11. Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    JAMA; 1977 Jun; 237(23):2471. PubMed ID: 576957
    [No Abstract]   [Full Text] [Related]  

  • 12. Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer.
    Langhammer H; Sintermann R; Hör G; Pabst HW
    Nuklearmedizin; 1978 Jul; 17(3):87-91. PubMed ID: 568257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
    Bhanalaph T; Varkarakis MJ; Murphy GP
    Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
    Smith RB; Walsh PC; Goodwin WE
    J Urol; 1973 Jul; 110(1):106-8. PubMed ID: 4713345
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostatic adenocarcinoma of ductal origin.
    Dube VE; Farrow GM; Greene LF
    Cancer; 1973 Aug; 32(2):402-9. PubMed ID: 4124700
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
    Nagel R; Kölln CP
    Med Klin; 1976 Oct; 71(41):1724-8. PubMed ID: 824540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of osteoblastic metastases from carcinoma of the prostate following therapy with tamoxifen.
    Amin R
    Br J Radiol; 1986 Jul; 59(703):703-4. PubMed ID: 3730770
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of malignant disease metastatic to bone by hormonal alterations.
    Mellette SJ
    Clin Orthop Relat Res; 1970; 73():73-88. PubMed ID: 5479779
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate.
    Morales A; Burr RC; Bruce AW
    Can Med Assoc J; 1970 Aug; 103(4):372-3. PubMed ID: 5447717
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proceedings: Value of cyproterone in the treatment of prostatic cancers with metastases].
    Bracci U
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):405-6. PubMed ID: 4804409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.